Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Artes Expands Collaboration With Rhein Minapharm
Artes Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm have reported the successful production of a new target of a therapeutic protein. This is the first result
Artes Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm have reported the successful production of a new target of a therapeutic protein. This is the first result
Catalent Pharma Solutions has received ISO 15378 certification of its Printed Components facility in Dublin, Ireland. Reportedly, Catalent is the first secondary packaging company in Ireland to achieve
Spherix has reported positive interim Phase 3 clinical results for the planned review of the NEET (Naturlose (D-tagatose) Efficacy Evaluation Trial) trial of D-tagatose in drug naive patients.
NovaDel Pharma (NovaDel) has enter into an exclusive license and distribution agreement with ECR Pharmaceuticals, a wholly owned subsidiary of Hi-Tech Pharmacal to commercialise and manufacture ZolpiMist in the
GlaxoSmithKline (GSK) and Nabi Biopharmaceuticals (Nabi) have reported a licensing agreement for a nicotine conjugate candidate vaccine (NicVAX), and for the development of a second generation nicotine vaccine.
First Aid Only has introduced a new line of First Aid Supplies, which are conveniently packaged in a lightweight yet durable plastic tube for consumers. Part of the
PPD has entered an agreement with Janssen Pharmaceutica to develop and commercialise two Phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome (IBS-d) and the other
Wedgewood Pharmacy is compounding oseltamivir phosphate in a cherry-flavored suspension in response to the nationwide shortage of Tamiflu suspension. The commercially manufactured Tamiflu product, from F Hoffmann-La Roche,
NeurogesX has received approval from FDA for Qutenza (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to
Sanofi Pasteur has reported that the French drug agency has granted marketing authorisation in France for Panenza, its non-adjuvanted Influenza A(H1N1) 2009 monovalent vaccine. The vaccine was made